Seasonal influenza vaccines induced high levels of neutralizing cross-reactive antibody responses against different genetic group influenza A(H1N1)pdm09 viruses

被引:4
|
作者
Haveri, Anu [1 ]
Ikonen, Niina [1 ]
Kantele, Anu [2 ,3 ]
Anttila, Veli-Jukka [2 ,3 ]
Ruotsalainen, Eeva [2 ,3 ]
Savolainen-Kopra, Carita [1 ]
Julkunen, Ilkka [1 ,4 ,5 ]
机构
[1] Natl Inst Hlth & Welf THL, Dept Hlth Secur, Expert Microbiol Unit, POB 30, Helsinki 00271, Finland
[2] Univ Helsinki, Inflammat Ctr, Div Infect Dis, POB 348, Hus Helsinki 00029, Finland
[3] Helsinki Univ Hosp, POB 348, Hus Helsinki 00029, Finland
[4] Univ Turku, Inst Biomed, Kiinamyllynkatu 10, FIN-20520 Turku, Finland
[5] Turku Univ Hosp, Kiinamyllynkatu 10, FIN-20520 Turku, Finland
关键词
Antibodies; Microneutralization test; Humoral immunity; Influenza A; Pandemic; Vaccine; HEMAGGLUTINATION INHIBITION; H1N1; 2009; ANTIGENIC STRUCTURE; PHASE-III; IMMUNOGENICITY; SAFETY; VACCINATION; CANDIDATE; CHILDREN; A(H3N2);
D O I
10.1016/j.vaccine.2019.03.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Influenza A(H1N1)pdm09 viruses have been circulating throughout the world since the 2009 pandemic. A/California/07/2009 (H1N1) virus was included in seasonal influenza vaccines for seven years altogether, providing a great opportunity to analyse vaccine-induced immunity in relation to the postpandemic evolution of the A(H1N1)pdm09 virus. Serum antibodies against various epidemic strains of influenza A (H1N1)pdm09 viruses were measured among health care workers (HCWs) by haemagglutination inhibition and microneutralization tests before and after 2010 and 2012 seasonal influenza vaccinations. We detected high responses of vaccine-induced neutralizing antibodies to six distinct genetic groups. Our results indicate antigenic similarity between vaccine and circulating A(H1N1)pdm09 strains, and substantial vaccine-induced immunity against circulating epidemic viruses. (C) 2019 Published by Elsevier Ltd.
引用
收藏
页码:2731 / 2740
页数:10
相关论文
共 50 条
  • [1] Antibody responses against influenza A(H1N1)pdm09 virus after sequential vaccination with pandemic and seasonal influenza vaccines in Finnish healthcare professionals
    Strengell, Mari
    Ikonen, Niina
    Ziegler, Thedi
    Kantele, Anu
    Anttila, Veli-Jukka
    Julkunen, Ilkka
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2013, 7 (03) : 431 - 438
  • [2] Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: Systematic review and meta-analyses
    Yin, Jiehui Kevin
    Chow, Maria Yui Kwan
    Khandaker, Gulam
    King, Catherine
    Richmond, Peter
    Heron, Leon
    Booy, Robert
    VACCINE, 2012, 30 (21) : 3209 - 3222
  • [3] Responses to A(H1N1)pdm09 Influenza Vaccines in Participants Previously Vaccinated With Seasonal Influenza Vaccine: A Randomized, Observer-Blind, Controlled Study
    Roy-Ghanta, Sumita
    Van der Most, Robbert
    Li, Ping
    Vaughn, David W.
    JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (09) : 1419 - 1430
  • [4] Influenza A(H1N1)pdm09 virus and asthma
    Obuchi, Masatsugu
    Adachi, Yuichi
    Takizawa, Takenori
    Sata, Tetsutaro
    FRONTIERS IN MICROBIOLOGY, 2013, 4
  • [5] Clinical and Immune Responses to Inactivated Influenza A(H1N1)pdm09 Vaccine in Children
    Kotloff, Karen L.
    Halasa, Natasha B.
    Harrison, Christopher J.
    Englund, Janet A.
    Walter, Emmanuel B.
    King, James C.
    Creech, C. Buddy
    Healy, Sara A.
    Dolor, Rowena J.
    Stephens, Ina
    Edwards, Kathryn M.
    Noah, Diana L.
    Hill, Heather
    Wolff, Mark
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (08) : 865 - 871
  • [6] A(H1N1) pdm09 influenza infection: vaccine inefficiency
    Friedman, Nehemya
    Drori, Yaron
    Pando, Rakefet
    Glatman-Freedman, Aharona
    Sefty, Hanna
    Bassal, Ravit
    Stein, Yaniv
    Shohat, Tamy
    Mendelson, Ella
    Hindiyeh, Musa
    Mandelboim, Michal
    ONCOTARGET, 2017, 8 (20) : 32856 - 32863
  • [7] Influenza A(H1N1)pdm09 virus: therapeutics and challenges
    Saxena, Shailendra K.
    Kotikalapudi, Rosaiah
    Tiwari, Sneham
    Muvva, Charuvaka
    FUTURE VIROLOGY, 2012, 7 (10) : 947 - 950
  • [8] Neurological events related to influenza A (H1N1) pdm09
    Cardenas, Graciela
    Luis Soto-Hernandez, Jose
    Diaz-Alba, Alexandra
    Ugalde, Yair
    Merida-Puga, Jorge
    Rosetti, Marcos
    Sciutto, Edda
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2014, 8 (03) : 339 - 346
  • [9] Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza
    Ortqvist, Ake
    Bennet, Rutger
    Rinder, Malin Ryd
    Lindblad, Hans
    Eriksson, Margareta
    VACCINE, 2012, 30 (39) : 5699 - 5702
  • [10] Influenza A(H1N1)pdm09 during air travel
    Neatherlin, John
    Cramer, Elaine H.
    Dubray, Christine
    Marienau, Karen J.
    Russell, Michelle
    Sun, Hong
    Whaley, Melissa
    Hancock, Kathy
    Duong, Krista K.
    Kirking, Hannah L.
    Schembri, Christopher
    Katz, Jacqueline M.
    Cohen, Nicole J.
    Fishbein, Daniel B.
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2013, 11 (02) : 110 - 118